Supplementary Table 4 from Colorectal Cancer Recurrence Prediction Using a Tissue-Free Epigenomic Minimal Residual Disease Assay
Nakamura Y., Tsukada Y., Matsuhashi N., Murano T., Shiozawa M., Takahashi Y., Oki E., Goto M., Kagawa Y., Kanazawa A., Ohta T., Ouchi A., Bando H., Uchigata H., Notake C., Ikematsu H., Yoshino T.
<p>Supplementary Table 4. Risk of recurrence based on ctDNA detection 28 days post-surgery for patients with stage II or higher CRC. Tables to accompany Figures 4B-D.</p>

